Baxter International

BAX50

S&P500

$38.76arrow_drop_down1.54%-$0.61

S&P500

BAX50

$38.76

arrow_drop_down1.54%-$0.61

S&P500

Performance History

Key Stats
Open	$39.68
Prev. Close	$39.37
EPS	-0.30

Next Earnings Date	Jan 2, 2025


PE Ratio	-

	LOW	HIGH
Day Range	38.62	39.71
52 Week Range	31.01	44.01

Ratios







EPS	-0.30

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Baxter International (BAX)

Baxter International Inc. (BAX) is a global healthcare company that focuses on innovative technologies and therapies for critical care, renal care, and surgical care. With a rich history dating back to 1931, Baxter has established itself as a leader in the healthcare industry, delivering life-saving products to patients around the world.

The stock price of Baxter International Inc. (BAX) has shown strong performance in recent years, reflecting the company's solid financial position and strategic initiatives. The stock has seen a steady upward trajectory, reaching new highs and outperforming the broader market. Investors have been attracted to the company's consistent growth, robust product portfolio, and commitment to innovation.

Websitecall_made

Sector: Healthcare
Industry: Medical Instruments & Supplies
CEO: Mr. Jose E. Almeida
Headquarters: Deerfield
Employees: 60000
Exchange: NYSE

Keep an eye on Baxter International

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Baxter International 's (BAX) price per share?

The current price per share for Baxter International (BAX) is $38.76. The stock has seen a price change of -$0.61 recently, indicating a -1.55% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Baxter International (BAX)?

For Baxter International (BAX), the 52-week high is $44.01, which is 13.54% from the current price. The 52-week low is $31.01, the current price is 24.99% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Baxter International (BAX) a growth stock?

Baxter International (BAX) has shown an average price growth of 0.41% over the past three years. It has received a score of 25 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Baxter International as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Baxter International (BAX) stock price performance year to date (YTD)?

As of the latest data, Baxter International (BAX) has a year-to-date price change of -0.23%. Over the past month, the stock has experienced a price change of 6.31%. Over the last three months, the change has been 14.91%. Over the past six months, the figure is -6.69%. Looking at a longer horizon, the five-year price change stands at -55.67%.

help

Is Baxter International (BAX) a profitable company?

Baxter International (BAX) has a net income of -$69M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 33.59% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 9.58% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $14.81B, although specific revenue growth data is currently not available. The gross profit is $4.98B. Operating income is noted at $390M. Furthermore, the EBITDA is $2.14B.

help

What is the market capitalization of Baxter International (BAX)?

Baxter International (BAX) has a market capitalization of $20.31B. The average daily trading volume is 3.51M, indicating the stock's liquidity and investor engagement.